Related Experiment Videos

Reduced membrane protein methylation in red cells of the McLeod blood group phenotype

E Wainfan1, M Kilkenny, C Johnson

  • 1Lindsley F. Kimball Research Institute, New York Blood Center, New York.

Transfusion
|November 1, 1991
PubMed

Insights

Red blood cells (RBCs) show altered protein methylation in McLeod syndrome. Membrane protein methylation is reduced in McLeod RBCs compared to control cells, indicating a biochemical abnormality.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Red blood cells (RBCs) possess protein methylase II, an enzyme crucial for methyl group transfer.
  • This enzyme plays a role in modifying aspartyl and glutamyl residues within proteins.

Purpose of the Study:

  • To investigate protein methylation differences in McLeod, Ko, and control RBCs.
  • To explore the biochemical basis of McLeod RBC abnormalities.

Main Methods:

  • Assaying enzyme-catalyzed methyl group transfer from S-adenosylmethionine to membrane proteins.
  • Utilizing radiolabeled methyl groups (14C or 3H) for quantification.
  • Employing ovalbumin as a methyl-accepting substrate.
  • Analyzing methyl-labeled polypeptides using slab gel electrophoresis.

Main Results:

  • McLeod cell membranes exhibited approximately 50% less methyl group uptake compared to control and Ko cells.
  • No significant differences in protein carboxymethyltransferase activity were observed when using ovalbumin.
  • Slab gel electrophoresis revealed no qualitative differences in methyl-labeled polypeptides between McLeod and control cells.

Conclusions:

  • McLeod RBCs display reduced membrane protein methylation, suggesting a specific biochemical defect.
  • The exact mechanisms underlying altered methylation in McLeod cells require further investigation.
  • These findings support the concept of a pleiotropic biochemical lesion in McLeod RBCs, linked to their acanthocytic morphology.

Related Concept Videos